Clinical Study to Evaluate the Performance of the INSTI® HCV Antibody Test for CLIA-Waived Use

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
multicenter prospective study to evaluate the clinical performance, usability and contrived result interpretation of the INSTI® HCV Antibody Test (INSTI HCV) with fingerstick (FS) whole blood specimens from participants with signs or symptoms of hepatitis or participants at risk for hepatitis C infection, by untrained operators at CLIA Waived settings.
Epistemonikos ID: 74c0829a4dca756d58d71fb35c3374002041c102
First added on: Oct 30, 2026